Language Select
Logotipo da Varian

Notícias recentes

Agosto 08, 2019
This afternoon, Varian (NYSE: VAR) posted a presentation providing an overview of the recently proposed radiation oncology alternative payment model and calendar year 2020 rates by the Center for... Read more
Agosto 08, 2019
Varian (NYSE: VAR) today announced that its executive staff will be meeting with analysts and investors at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago on Monday,... Read more
Agosto 05, 2019
Varian (NYSE: VAR) today announced that the newly proposed tariffs by the U.S. on the remaining $300 billion of Chinese imports should have no material impact to the company. Last Thursday, the... Read more

Postagens recentes do blog

Jul 08, 2019 | Centerline
Since its introduction in 2017, Varian’s HyperArc™ high-definition radiotherapy has been deployed to deliver noncoplanar stereotactic radiosurgery (SRS) at sites around the world. Physicists in the... Read more
Jun 27, 2019 | Centerline
After 20 years with one oncology information system (OIS), migrating to a new one is a serious step, but it’s one that Baton Rouge General took in the summer of 2016 with an eye to the future for its... Read more
Jun 10, 2019 | Centerline
Varian has acquired Endocare, based in Austin, Texas; and Alicon, based in Hangzhou, China. Endocare is a leading provider of technology for cryoablation and microwave ablation. In China, Alicon is... Read more

Receba notícias por e-mail
Assinar agora

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com